4751
4752
4753
4754
4755
4756
4757
4758
4759
Koopman, C, Vaartjes, I, Blokstra, A, Verschuren, W M M, Visser, M, Deeg, D J H, Bots, M L, van Dis, I
Veröffentlicht in: Koopman , C , Vaartjes , I , Blokstra , A , Verschuren , W M M , Visser , M , Deeg , D J H , Bots , M L & van Dis , I 2016 , ' Trends in risk factors for coronary heart disease in the Netherlands ' , BMC Public Health , vol. 16 , no. 1 , pp. 835 . https://doi.org/10.1186/s12889-016-3526-7;
2016
Veröffentlicht in: Koopman , C , Vaartjes , I , Blokstra , A , Verschuren , W M M , Visser , M , Deeg , D J H , Bots , M L & van Dis , I 2016 , ' Trends in risk factors for coronary heart disease in the Netherlands ' , BMC Public Health , vol. 16 , no. 1 , pp. 835 . https://doi.org/10.1186/s12889-016-3526-7;
2016
4760
Korthals-de Bos, I.B.C., Smidt, N., van Tulder, M.W., Rutten-van Molken, M.P.M.H., Ader, H.J., van der Windt, D.A.W.M., Assendelft, W.J.J., Bouter, L.M.
Veröffentlicht in: Korthals-de Bos , I B C , Smidt , N , van Tulder , M W , Rutten-van Molken , M P M H , Ader , H J , van der Windt , D A W M , Assendelft , W J J & Bouter , L M 2004 , ' Cost effectiveness of interventions for lateral epicondylitis: results from a randomised controlled trial in primary care. ' , Pharmaco Economics , vol. 22 , no. 3 , pp. 185-195 . https://doi.org/10.2165/00019053-200422030-00004;
2004
Veröffentlicht in: Korthals-de Bos , I B C , Smidt , N , van Tulder , M W , Rutten-van Molken , M P M H , Ader , H J , van der Windt , D A W M , Assendelft , W J J & Bouter , L M 2004 , ' Cost effectiveness of interventions for lateral epicondylitis: results from a randomised controlled trial in primary care. ' , Pharmaco Economics , vol. 22 , no. 3 , pp. 185-195 . https://doi.org/10.2165/00019053-200422030-00004;
2004